LAG‐3 is a dominant checkpoint regulator of CD4+ T cell effector function in malaria; its blockade enhances parasite clearance independent of humoral immunity, suggesting potential for targeted immunotherapy to restore T cell function and accelerate parasite elimination. This evidence concerns the gene LAG3 and malaria.